CLINICAL_TRIALS
trial_result
· 2025-07-23
Clinical Trial Update: Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate [Phase 3]
Summary
Phase 3 study evaluating 6-month subcutaneous triptorelin in adult men with prostate cancer. The trial results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ipsen | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2025-07-23